Clinical Trial Update: Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094 [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov update reporting long-term safety and clinical outcomes of idursulfase IT and Elaprase in pediatric participants who completed prior Hunter s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome

Drugs mentioned

• Elaprase (idursulfase)
• Idursulfase-IT (idursulfase-IT)

Snippet

Sponsor: Shire | Conditions: Hunter Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-06-19